Loading
pharmacopuncture therapy / Conventional therapy / Aromatase Inhibitor Induced Arthralgia · Interventional Study
ClinicalTrials.gov · September 11, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned pragmatic pilot trial comparing pharmacopuncture to conventional therapy in patients with aromatase inhibitor-induced arthralgia. The study is currently recruiting; no results are posted in this registry record, and the evidence base remains preliminary until completion and publication.
Interventional, Randomized, Parallel, Single masking, Treatment purpose. Breast Cancer, Aromatase Inhibitor, Aromatase Inhibitor Induced Arthralgia; Female; age from 19 Years; to 75 Years. Intervention: Pharmacopuncture group. Compared with: Control group — Active Comparator. n = 30. 3 sites: South Korea.
This is a planned pragmatic pilot trial comparing pharmacopuncture to conventional therapy in patients with aromatase inhibitor-induced arthralgia. The study is currently recruiting; no results are posted in this registry record, and the evidence base remains preliminary until completion and publication.
Blinding status, allocation concealment, and safety monitoring details not reported in registry record
The source did not state who this applies to in practice.
This is a recruiting pilot trial with no posted results; the registry record describes only the planned design and endpoints, not outcomes.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07789717). This is a study registration, not published results. Lead sponsor: Ilsan Cha hospital. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 30 participants (ESTIMATED). Conditions: Breast Cancer, Aromatase Inhibitor, Aromatase Inhibitor Induced Arthralgia. Interventions: PROCEDURE: pharmacopuncture therapy; PROCEDURE: Conventional therapy. Primary outcome measures: Change in Brief pain inventory-Korean version (BPI-K) , visit 13 (week 6). Brief summary: This is a pragmatic pilot trial designed to compare and evaluate the efficacy, safety, and cost-effectiveness of pharmacopuncture treatment versus a control group in aromatase inhibitor-induced arthralgia patients with breast cancer.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.